NYSE:SNY - Sanofi Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$43.55 -0.60 (-1.36 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$43.55
Today's Range$43.55 - $43.98
52-Week Range$37.43 - $50.65
Volume1.59 million shs
Average Volume842,605 shs
Market Capitalization$110.73 billion
P/E Ratio13.91
Dividend Yield2.73%
Beta0.85
Sanofi logoSanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an oral immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis. The company also provides Jevtana, a taxane derivative for prostate cancer; Taxotere, a taxoid for cancers; Eloxatin, a platinum agent for colorectal cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, a hematopoietic stem cell mobilizer; and Zaltrap, a protein for metastatic colorectal cancer. In addition, it offers Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl, an oral sulfonylurea; Lyxumia/Adlyxin, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; and Praluent, a cholesterol-lowering drug and Multaq, an anti-arrhythmic drug for atrial fibrillation. Further, the company provides Plavix, an anti-platelet agent for atherothrombotic conditions; Lovenox, a heparin for the prophylaxis and venous thromboembolism and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela oral phosphate binders for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; and Allegra, an anti-histamine for seasonal allergic rhinitis and uncomplicated hives. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines. Sanofi has strategic alliance with Sensile Medical Ltd.; and partnership with REVOLUTION Medicines, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Receive SNY News and Ratings via Email

Sign-up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNYSE:SNY
CUSIPN/A
Phone33-1-53-77-44-00

Debt

Debt-to-Equity Ratio0.40
Current Ratio1.22
Quick Ratio0.85

Price-To-Earnings

Trailing P/E Ratio13.91
Forward P/E Ratio13.87
P/E Growth2.37

Sales & Book Value

Annual Sales$39.60 billion
Price / Sales2.76
Cash Flow$4.7081 per share
Price / Cash9.25
Book Value$26.11 per share
Price / Book1.67

Profitability

EPS (Most Recent Fiscal Year)$3.13
Net Income$4.28 billion
Net Margins10.29%
Return on Equity23.77%
Return on Assets12.79%

Miscellaneous

Employees106,566
Outstanding Shares2,508,090,000
Market Cap$110.73 billion

Sanofi (NYSE:SNY) Frequently Asked Questions

What is Sanofi's stock symbol?

Sanofi trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNY."

How often does Sanofi pay dividends? What is the dividend yield for Sanofi?

Sanofi announced an annual dividend on Tuesday, February 13th. Investors of record on Thursday, May 10th will be paid a dividend of $1.8609 per share on Monday, June 4th. This represents a yield of 4.72%. The ex-dividend date is Wednesday, May 9th. This is a boost from Sanofi's previous annual dividend of $1.58. View Sanofi's Dividend History.

How were Sanofi's earnings last quarter?

Sanofi SA (NYSE:SNY) posted its quarterly earnings results on Tuesday, July, 31st. The company reported $0.74 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.72 by $0.02. The business earned $8.18 billion during the quarter, compared to analysts' expectations of $8.27 billion. Sanofi had a net margin of 10.29% and a return on equity of 23.77%. The firm's revenue for the quarter was down 5.6% on a year-over-year basis. During the same quarter last year, the company earned $1.35 EPS. View Sanofi's Earnings History.

When is Sanofi's next earnings date?

Sanofi is scheduled to release their next quarterly earnings announcement on Wednesday, October, 31st 2018. View Earnings Estimates for Sanofi.

What price target have analysts set for SNY?

13 brokerages have issued 12 month price targets for Sanofi's stock. Their predictions range from $45.00 to $55.00. On average, they anticipate Sanofi's stock price to reach $49.00 in the next year. This suggests a possible upside of 12.5% from the stock's current price. View Analyst Price Targets for Sanofi.

What is the consensus analysts' recommendation for Sanofi?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Sanofi.

Are investors shorting Sanofi?

Sanofi saw a decline in short interest during the month of August. As of August 15th, there was short interest totalling 2,686,061 shares, a decline of 41.0% from the July 31st total of 4,554,476 shares. Based on an average daily volume of 2,948,611 shares, the short-interest ratio is presently 0.9 days. View Sanofi's Current Options Chain.

Who are some of Sanofi's key competitors?

Who are Sanofi's key executives?

Sanofi's management team includes the folowing people:
  • Mr. Olivier Brandicourt, CEO & Director (Age 62)
  • Mr. Jérôme Contamine, CFO & Exec. VP (Age 61)
  • Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard, Chief Information officer
  • Mr. George Grofik, Head of Investor Relations

Who are Sanofi's major shareholders?

Sanofi's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (0.62%), FMR LLC (0.32%), Bank of America Corp DE (0.25%), BlackRock Inc. (0.13%), Macquarie Group Ltd. (0.12%) and Brandes Investment Partners LP (0.11%). View Institutional Ownership Trends for Sanofi.

Which major investors are selling Sanofi stock?

SNY stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Senzar Asset Management LLC, Sio Capital Management LLC, Wells Fargo & Company MN, Federated Investors Inc. PA, Raymond James & Associates, FDx Advisors Inc. and Point72 Asset Management L.P.. View Insider Buying and Selling for Sanofi.

Which major investors are buying Sanofi stock?

SNY stock was bought by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Hamlin Capital Management LLC, American Century Companies Inc., OLD Mission Capital LLC, Jane Street Group LLC, Brandes Investment Partners LP, SG Americas Securities LLC and Stephens Inc. AR. View Insider Buying and Selling for Sanofi.

How do I buy shares of Sanofi?

Shares of SNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sanofi's stock price today?

One share of SNY stock can currently be purchased for approximately $43.55.

How big of a company is Sanofi?

Sanofi has a market capitalization of $110.73 billion and generates $39.60 billion in revenue each year. The company earns $4.28 billion in net income (profit) each year or $3.13 on an earnings per share basis. Sanofi employs 106,566 workers across the globe.

What is Sanofi's official website?

The official website for Sanofi is http://www.sanofi.com.

How can I contact Sanofi?

Sanofi's mailing address is 54 RUE LA BOETIE, PARIS I0, 75008. The company can be reached via phone at 33-1-53-77-44-00 or via email at [email protected]


MarketBeat Community Rating for Sanofi (NYSE SNY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  353 (Vote Outperform)
Underperform Votes:  447 (Vote Underperform)
Total Votes:  800
MarketBeat's community ratings are surveys of what our community members think about Sanofi and other stocks. Vote "Outperform" if you believe SNY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel